1.Modulating protein kinase D1 signal transduction.
Wei ZHANG ; Jian XU ; Chang-ku JIA ; Shu-sen ZHENG
Chinese Medical Journal 2009;122(15):1816-1820
2.Effect of SH2A gene in cell signal transduction and its subcellular locolization.
Qian DING ; Yan-yan ZHAO ; Zhi-jun SUN ; Da-hai YU
Chinese Journal of Medical Genetics 2003;20(6):499-503
OBJECTIVETo examine the effect of SH2A gene in cell signal transduction and its subcellular localization.
METHODSRT-PCR method was used to amplify the coding sequence of SH2A gene. Eukaryotic recombined expression vector pcDNA 3.1-SH2A was constructed, and then Bel7402 cell and COS7 cell transfected by liposome. Multiple kinase assay was performed to examine the activity of protein kinase (PKC), mitogen activated protein kinase (MAPK), tyrosine protein kinase (TPK) in the transfected cells. Meantime, pEGFP-SH2A vector was also constructed and the cells transfected with it were examined by fluorescent microscopy.
RESULTSRecombined expression vector pcDNA3.2-SH2A and pEGFP-SH2A contained the coding sequence of SH2A cDNA. In both cell lines expressing SH2A gene, the cytoplasm PKC activity decreased by 40% or so, but no apparent alteration was found in MAPK and TPK activity. SH2A gene was found localized in the cytoplasm of transfected cells under fluorescent microscope.
CONCLUSIONSH2A gene may act as an inhibiting factor in PKC signal transduction, and it is localized in cytoplasm.
Animals ; COS Cells ; Cytoplasm ; chemistry ; Humans ; Membrane Proteins ; analysis ; genetics ; physiology ; Mitogen-Activated Protein Kinases ; metabolism ; Protein Kinase C ; physiology ; Signal Transduction ; physiology ; Transfection
3.The promoting research of phospholipase C epsilon-1 on nasal Th2 cell polarization.
Bing ZHANG ; Tao LIU ; Huarong ZHOU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(17):1363-1366
Phospholipase C epsilon-1 (PLCE1) is a phospholipase C isoenzyme encoded by PLCE1 gene, and has more complicated molecular structure and function than other subtypes. Phospholipase C epsilon-1 is accepted the dual regulation by the upstream G proteins and GTP enzymes of Ras family. The downstream signal of PLCE1 is not only cause the Ca2+ flow and protein kinase C(PKC) activation, but also can be used as the GTP enzyme guanylic acid conversion factor of Ras superfamily, so as to regulate the expression of certain genes, adjusting cell growth and differentiation processes. PLCE1 plays a very important role in the signal transduction in the regulation of cell growth, differentiation, proliferation and apoptosis. Previous studies showed that phospholipase C epsilon-1 played an important role in the development of malignant tumors (especially the digestive tumors), heart disease, nephrotic syndrome and other diseases, but there are some questions about the mechanisms of PLCE1 involved in allergic rhinitis, this article will make an overview about PLCE1 promotes allergic rhinitis CD4+ T cells differentiate to Th2 cells by PKC-NF-κB pathway and Ras-MAPK pathway.
Apoptosis
;
Calcium
;
metabolism
;
Cell Cycle
;
Cell Differentiation
;
physiology
;
Cell Proliferation
;
physiology
;
Enzyme Activation
;
Gene Expression
;
Humans
;
NF-kappa B
;
Phosphoinositide Phospholipase C
;
genetics
;
physiology
;
Protein Kinase C
;
metabolism
;
Rhinitis, Allergic
;
enzymology
;
Signal Transduction
;
Th2 Cells
;
cytology
4.PKC alpha induces differentiation through ERK1/2 phosphorylation in mouse keratinocytes.
Haeng Ran SEO ; Yoo Wook KWAN ; Chul Koo CHO ; Sangwoo BAE ; Su Jae LEE ; Jae Won SOH ; Hee Yong CHUNG ; Yun Sil LEE
Experimental & Molecular Medicine 2004;36(4):292-299
Epidermal keratinocyte differentiation is a tightly regulated stepwise process that requires protein kinase C (PKC) activation. Studies on cultured mouse keraitnocytes induced to differentiate with Ca2+ have indirectly implicated the involvement of PKC alpha isoform. When PKC alpha was overexpressed in undifferentiated keratinocytes using adenoviral system, expressions of differentiation markers such as loricrin, filaggrin, keratin 1 (MK1) and keratin 10 (MK10) were increased, and ERK1/2 phosphorylation was concurrently induced without change of other MAPK such as p38 MAPK and JNK1/2. Similarly, transfection of PKC alphakinase active mutant (PKC alpha- CAT) in the undifferentiated keratinocyte, but not PKC beta-CAT, also increased differentiation marker expressions. On the other hand, PKC alphadominant negative mutant (PKC beta-KR) reduced Ca2+ -mediated differentiation marker expressions, while PKC beta-KR did not, suggesting that PKC alphais responsible for keratinocyte differentiation. When downstream pathway of PKC alphain Ca2+ - mediated differentiation was examined, ERK1/2, p38 MAPK and JNK1/2 phosphorylations were increased by Ca2+ shift. Treatment of keratinocytes with PD98059, MEK inhibitor, and SB20358, p38 MAPK inhibitor, before Ca2+ shift induced morphological changes and reduced expressions of differentiation markers, but treatment with SP60012, JNK1/2 inhibitor, did not change at all. Dominant negative mutants of ERK1/2 and p38 MAPK also inhibited the expressions of differentiation marker expressions in Ca2+ shifted cells. The above results indicate that both ERK1/2 and p38 MAPK may be involved in Ca2+- mediated differentiation, and that only ERK1/2 pathway is specific for PKCa-mediated differentiation in mouse keratinocytes.
Animals
;
Calcium/pharmacology/physiology
;
Cell Differentiation/physiology
;
Intermediate Filament Proteins/analysis/metabolism
;
Keratinocytes/cytology/*enzymology
;
Membrane Proteins/analysis/metabolism
;
Mice
;
Mitogen-Activated Protein Kinase 1/*metabolism
;
Mitogen-Activated Protein Kinase 3/*metabolism
;
Phosphorylation
;
Protein Kinase C/genetics/*physiology
;
Research Support, Non-U.S. Gov't
;
p38 Mitogen-Activated Protein Kinases/metabolism
5.Experimental study on apoptosis of leukemia cell line NB4 transfected with WT1 gene.
Hui-Ling SHEN ; Zi-Xing CHEN ; Wei WANG ; Jian-Nong CEN ; Shao-Yan HU ; Ye ZHAO
Journal of Experimental Hematology 2005;13(6):989-995
In order to study the potential effects of exogenous WT1 gene isoform on apoptosis in leukemia cell line NB4 and its possible molecular mechanisms, the eukaryotic expression recombinant vector (pCB6(+)/WTA) containing full-length human WT1 isoform (WTA: -17aa/-KTS) cDNA and the vacant vector-alone were introduced into the leukemia cell line NB4 respectively by electroporation. The WTA mRNA and protein in cells were detected by RT-PCR and Western blot. Binding of Annexin V were tested by flow cytometry and agarose gel electrophoresis to verify whether exogenous WTA could induce apoptosis of NB4 cells. Expressions of p21, p53, bcl-2, bcl-XL and c-myc genes were determined by semi-quantitative RT-PCR after introducing recombinant vectors into the NB4 cells. The results showed that in exposure to As(2)O(3) at 0.8 micromol/L for 48 hours, the NB4/WTA cells exhibited the morphological hallmarks of apoptosis, the marked DNA ladder shown by gel electrophoresis, and the enhanced apoptosis rate marked by Annexin V. RT-PCR showed an increase in p21 and c-myc genes expression, a decrease in bcl-2 and a relative constant expression of p53, bcl-XL in NB4/WTA cells. It is concluded that the introduction and expression of exogenous WTA gene can lead to apoptosis of NB4/WTA cells by down-regulating the Bcl-2 gene expression and up-regulating the p21 and c-myc genes expression.
Apoptosis
;
genetics
;
physiology
;
Blotting, Western
;
Cell Line, Tumor
;
Cyclin-Dependent Kinase Inhibitor p21
;
genetics
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Leukemia
;
genetics
;
metabolism
;
pathology
;
Proto-Oncogene Proteins c-bcl-2
;
genetics
;
Proto-Oncogene Proteins c-myc
;
genetics
;
RNA, Messenger
;
biosynthesis
;
genetics
;
Reverse Transcriptase Polymerase Chain Reaction
;
Transfection
;
Tumor Suppressor Protein p53
;
genetics
;
WT1 Proteins
;
genetics
;
metabolism
;
physiology
;
bcl-X Protein
;
genetics
6.Effect of cytoskeleton reorganization inhibition on the activation of extracellular signal-regulated kinase in osteoblasts by fluid shear stress.
Ying-Hui XIANG ; Min-Feng SHAO ; Yang SONG ; Zhi YANG ; Xiao-Dan CHEN ; Qiang FU
Chinese Journal of Stomatology 2012;47(11):680-683
OBJECTIVETo investigate the effect of cytoskeleton reorganization inhibition with RNA interference on the activation of extracellular signal-regulated kinase (ERK1/2) in primary osteoblasts induced by fluid shear stress (FSS).
METHODSBALB/c mouse primary cultured osteoblasts were isolated by enzyme digestion technique. Osteoblasts were treated with LIM domain kinase 2 (LIM-2) specific siRNA or negative control siRNA, and then were loaded or unloaded by FSS of 1.2 Pa for 0, 5, 15, 30 and 60 min, respectively. The Western blotting was performed to detect the protein expression levels of P-ERK1/2 and ERK1/2, respectively. Two-way ANOVA and one-way ANOVA were used in data analysis.
RESULTSFSS loading for different time (0, 5, 15, 30, 60 min) treated with negative RNA inteference had significant effect on the levels of P-ERK/ERK ratio (0.047 ± 0.031, 0.253 ± 0.137, 0.390 ± 0.155, 0.613 ± 0.123, 0.680 ± 0.108, respectively, P < 0.01). Statistical analysis showed that there was significant interaction between FSS and cytoskeleton reorganization inhibition treated with RNA inteference on the levels of P-ERK/ERK ratio (P < 0.01). The levels of P-ERK/ERK ratio increased when osteoblasts were loaded for 5 - 15 min (0.623 ± 0.129 and 0.623 ± 0.064, respectively, P < 0.05) and returned to baseline at 30 min (0.333 ± 0.086), and then reached the peak at 60 min (0.667 ± 0.064, P < 0.01).
CONCLUSIONSFSS could activate ERK1/2 rapidly in primary cultured osteoblasts. Cytoskeleton reorganization inhibition treated with RNA interference speeded-up the activation of ERK1/2 by FSS, which could increase the sensitivity of ERK1/2 to FSS.
Animals ; Cells, Cultured ; Cytoskeleton ; metabolism ; physiology ; Lim Kinases ; genetics ; metabolism ; Mechanotransduction, Cellular ; Mice ; Mice, Inbred BALB C ; Mitogen-Activated Protein Kinase 1 ; metabolism ; Mitogen-Activated Protein Kinase 3 ; metabolism ; Osteoblasts ; cytology ; enzymology ; Phosphorylation ; RNA Interference ; RNA, Small Interfering ; Stress, Mechanical
7.Parathyroid hormone-mitogen-activated protein kinase axis exerts fibrogenic effect of connective tissue growth factor on human renal proximal tubular cells.
Yun-Shan GUO ; Wei-Jie YUAN ; Ai-Ping ZHANG ; Yao-Hai DING ; Yan-Xia WANG
Chinese Medical Journal 2010;123(24):3671-3676
BACKGROUNDEnhanced and prolonged expression of connective tissue growth factor (CTGF) is associated with kidney fibrosis. Parathyroid hormone (PTH) is involved in the genesis of disturbed calcium/phosphate metabolism and ostitis fibrosa in renal failure. PTH activated mitogen-activated protein kinase (MAPK) signaling pathway is present in renal tubular cells. The aim of this study was to identify the mechanism how the signal is transduced to result in extracellular signal-regulated protein kinase (ERK) activation, leading to upregulation of CTGF.
METHODSThe levels of CTGF mRNA and protein in human kidney proximal tubular cells (HK-2) treated with PTH in the presence or absence of the MAPK inhibitor PD98059 were analyzed by quantitative real-time polymerase chain reaction (RT-PCR) and immunoblotting assay. The activation of the CTGF promoter in HK-2 cells was determined by the dual-luciferase assay. The effects of the protein kinase A (PKA) activator 8-Br-cAMP and protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) on MAPK phosphorylation, and the effects of the PKA inhibitor H89 and PKC inhibitor calphostin C on MAPK phosphorylation and CTGF expression were detected by immunoblotting assay.
RESULTSPD98059 inhibited the PTH stimulated expression of CTGF, which strongly suggested that the MAPK signaling pathway plays an important role in the PTH-induced CTGF upregulation in renal tubular cells. A PKA activator as well as PKC activators induced MAPK phosphorylation, and both PKA and PKC inhibitors antagonized PTH-induced MAPK phosphorylation and CTGF expression.
CONCLUSIONCTGF expression is upregulated by PTH through a PKC/PKA-ERK-dependent pathway.
Cells, Cultured ; Connective Tissue Growth Factor ; genetics ; physiology ; Cyclic AMP-Dependent Protein Kinases ; physiology ; Extracellular Signal-Regulated MAP Kinases ; physiology ; Fibrosis ; Flavonoids ; pharmacology ; Humans ; Kidney Tubules, Proximal ; metabolism ; pathology ; MAP Kinase Signaling System ; Mitogen-Activated Protein Kinases ; physiology ; Parathyroid Hormone ; pharmacology ; Phosphorylation ; Protein Kinase C ; physiology
8.Transcription of the protein kinase C-delta gene is activated by JNK through c-Jun and ATF2 in response to the anticancer agent doxorubicin.
Byong Wook MIN ; Chang Gun KIM ; Jesang KO ; Yoongho LIM ; Young Han LEE ; Soon Young SHIN
Experimental & Molecular Medicine 2008;40(6):699-708
Expression of protein kinase C-delta (PKC delta) is up-regulated by apoptosis-inducing stimuli. However, very little is known about the signaling pathways that control PKC delta gene transcription. In the present study, we demonstrate that JNK stimulates PKC delta gene expression via c-Jun and ATF2 in response to the anticancer agent doxorubicin (DXR) in mouse lymphocytic leukemia L1210 cells. Luciferase reporter assays showed that DXR-induced activation of the PKC delta promoter was enhanced by ectopic expression of JNK1, c-Jun, or ATF2, whereas it was strongly reduced by expression of dominant negative JNK1 or by treatment with the JNK inhibitor SP600125. Furthermore, point mutations in the core sequence of the c-Jun/ATF2 binding site suppressed DXR-induced activation of the PKC delta promoter. Our results suggest an additional role for a JNK signaling cascade in DXR-induced PKC delta gene expression.
Activating Transcription Factor 2/*physiology
;
Animals
;
Anthracenes/pharmacology
;
Antibiotics, Antineoplastic/*pharmacology
;
Apoptosis
;
Cell Line, Tumor
;
Doxorubicin/*pharmacology
;
Mice
;
Mitogen-Activated Protein Kinase 8/*physiology
;
Mutation
;
Promoter Regions, Genetic
;
Protein Kinase C-delta/genetics/*metabolism
;
Proto-Oncogene Proteins c-jun/antagonists & inhibitors/*physiology
;
Signal Transduction/physiology
;
Transcription, Genetic
9.Activated Protein C Protects Myocardium Via Activation of Anti-apoptotic Pathways of Survival in Ischemia-reperfused Rat Heart.
Jia Wang DING ; Xiao Hong TONG ; Jun YANG ; Zhao Qi LIU ; Yan ZHANG ; Jian YANG ; Song LI ; Li LI
Journal of Korean Medical Science 2010;25(11):1609-1615
Activated protein C (APC) is known to be beneficial on ischemia reperfusion injury in myocardium. However, the protection mechanism of APC is not fully understood. The purpose of this study was to investigate the effects and possible mechanisms of APC on myocardial ischemic damage. Artificially ventilated anaesthetized Sprague-Dawley rats were subjected to a 30 min of left anterior descending coronary artery occlusion followed by 2 hr of reperfusion. Rats were randomly divided into four groups; Sham, I/R, APC preconditioning and postconditioning group. Myocardial infarct size, apoptosis index, the phosphorylation of ERK1/2, Bcl-2, Bax and cytochrome c genes and proteins were assessed. In APC-administrated rat hearts, regardless of the timing of administration, infarct size was consistently reduced compared to ischemia/reperfusion (I/R) rats. APC improved the expression of ERK1/2 and anti-apoptotic protein Bcl-2 which were significantly reduced in the I/R rats. APC reduced the expression of pro-apoptotic genes, Bax and cytochrome c. These findings suggest that APC produces cardioprotective effect by preserving the expression of proteins and genes involved in anti-apoptotic pathways, regardless of the timing of administration.
Animals
;
Apoptosis
;
Cytochromes c/genetics/metabolism
;
Hemodynamics/physiology
;
Male
;
Mitogen-Activated Protein Kinase 1/metabolism
;
Mitogen-Activated Protein Kinase 3/metabolism
;
Myocardial Reperfusion Injury/metabolism/pathology/*prevention & control
;
Myocardium/*metabolism/pathology
;
Phosphorylation
;
Protein C/*therapeutic use
;
Proto-Oncogene Proteins c-bcl-2/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Signal Transduction
;
bcl-2-Associated X Protein/metabolism
10.Heat shock activated Rac-MEKK-JNK pathway and hsp90 beta gene expression.
Xiao-yan LI ; Cheng LU ; Ning-hua WU ; Yu-fei SHEN
Acta Academiae Medicinae Sinicae 2002;24(3):264-268
OBJECTIVETo study the effect of Rac-MEKK-JNK (Rac-mitogen activated protein kinase kinase kinase-C-jun N-terminal protein kinase) signal pathway on heat shock-induced hsp90 beta gene expression and the impact of Hsp90 on the regulation of the pathway.
METHODSDN-Rac, DN-MEKK or DN-JNK were cotransfected with hsp90 beta CAT reporter plasmid beta 3.1 into Jurkat or LETPa-2 cells individually, the CAT mRNA expression was then determined quantitatively by competitive RT-PCR based system. Western blot was carried out to detect the expression level and phosphorylation of c-Jun in Jurkat and LETPa-2 cells that were transfected with DN-Rac, DN-MEKK or DN-JNK. By in vitro kinase activity assay and Western blot, the effect of geldnamycin (GA) on heat induced JNK activity were evaluated.
RESULTSIn Jurkat cell transfected with DN-Rac, DN-MEKK or DN-JNK, heat shock induced relative CAT mRNA expression level was decreased to (72.8 +/- 5)%, (60 +/- 13.2)% and (47.7 +/- 12.1)% of the control respectively; while in LETPa-2 cell hsp90 beta 3.1 reporter gene expression was accordingly suppressed to (16.17 +/- 5.1)%, (50.2 +/- 8.7)% and (47.5 +/- 10)% of control. C-Jun expression and phosphorylation were inhibited by the transfection of either one of DN-Rac, DN-MEKK or DN-JNK. With GA treatment, heat shock induced JNK activity was repressed, while the expression level of JNK or c-Jun was not obviously changed.
CONCLUSIONSRac-MEKK-JNK pathway promotes heat shock induced hsp90 beta gene expression and hsp90 may participate in the regulation of heat shock activated Rac-MEKK-JNK signal pathway in both Jurkat and LETPa-2 cells.
Benzoquinones ; Cell Line, Tumor ; Genes, Reporter ; HSP90 Heat-Shock Proteins ; biosynthesis ; genetics ; Hot Temperature ; Humans ; JNK Mitogen-Activated Protein Kinases ; Lactams, Macrocyclic ; Leukemia, T-Cell ; pathology ; Mitogen-Activated Protein Kinase Kinases ; physiology ; Mitogen-Activated Protein Kinases ; physiology ; Protein Kinase C ; physiology ; Quinones ; pharmacology ; Signal Transduction ; Transfection